| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S001340050329 |
| P698 | PubMed publication ID | 9083230 |
| P2093 | author name string | P Bauer | |
| B Levy | |||
| C Charpentier | |||
| G Audibert | |||
| A Larcan | |||
| P E Bollaert | |||
| P Nabet | |||
| L Nace | |||
| P433 | issue | 3 | |
| P921 | main subject | norepinephrine | Q186242 |
| hemodynamics | Q1642137 | ||
| septic shock | Q1765564 | ||
| epinephrine | Q28163586 | ||
| P304 | page(s) | 282-287 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study | |
| P478 | volume | 23 |
| Q44476206 | A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units |
| Q33736253 | Adjunctive drug treatment in severe hypoxic respiratory failure. |
| Q36342739 | Bench-to-bedside review: Is there a place for epinephrine in septic shock? |
| Q77408421 | Case 2-1999. Severe lactic acidosis after cardiac surgery: sign of perfusion deficits? |
| Q43813602 | Catecholamine dosing and survival in adult intensive care unit patients |
| Q37000855 | Choice of vasopressor in septic shock: does it matter? |
| Q24791055 | Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock |
| Q40736677 | Clinical use of lactate monitoring in critically ill patients. |
| Q91741502 | Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials |
| Q64055906 | Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials |
| Q41189097 | Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock |
| Q36689431 | Cumulative lactate and hospital mortality in ICU patients |
| Q33642584 | Current therapy for sepsis |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q50732937 | Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. |
| Q33235038 | Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. |
| Q41847224 | Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock. |
| Q44320915 | Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats |
| Q90166417 | Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience |
| Q42669733 | Epinephrine: is it really the black sheep of vasoactive agents? |
| Q51499835 | Gastric intramucosal pH-guided therapy in patients after elective repair of infrarenal abdominal aneurysms: is it beneficial? |
| Q28293196 | Gastrointestinal microcirculation: still a mystery? |
| Q38029246 | Hemodynamic management of cardiovascular failure by using PCO(2) venous-arterial difference. |
| Q37443126 | Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. |
| Q86913563 | Histological damage of colonic epithelium is associated with clinical severity and outcome in colectomized critically Ill patients |
| Q53929813 | Influence of epinephrine and norepinephrine on intestinal villous blood flow during endotoxemia. |
| Q37695510 | Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle |
| Q33227080 | Microcirculatory monitoring of sepsis |
| Q34994199 | Model-based prediction of the patient-specific response to adrenaline |
| Q51508422 | Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance. |
| Q35622651 | New approaches to the treatment of sepsis |
| Q34277717 | New evidence for old therapies in catecholamine-dependent septic shock |
| Q57778873 | Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial |
| Q26738929 | Pancreatic injury in patients with septic shock: A literature review |
| Q74292358 | Part 10: pediatric advanced life support. European Resuscitation Council |
| Q34983258 | Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock |
| Q33893308 | Pharmacologic issues in the management of septic shock |
| Q37236713 | Pharmacological optimization of tissue perfusion |
| Q37105993 | Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. |
| Q37845209 | Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature |
| Q34103368 | Rational use of vasoactive drugs after cardiac resuscitation: focus on inotropic agents |
| Q24795494 | Resolution and outcome of acute circulatory failure does not correlate with hemodynamics |
| Q37561662 | Role of nitroso radicals as drug targets in circulatory shock |
| Q46718672 | Sepsis therapy: present guidelines and their application |
| Q35687065 | Sepsis-induced cardiomyopathy |
| Q34285308 | Septic shock |
| Q42602282 | Septic shock resuscitation: what goals and how to achieve them? |
| Q36787207 | Severe hyperlactatemia with normal base excess: a quantitative analysis using conventional and Stewart approaches |
| Q77362601 | Survey of vasopressor usage |
| Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
| Q29615429 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 |
| Q24644984 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 |
| Q33652179 | Techniques to assess tissue oxygenation in the clinical setting |
| Q24794570 | The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine |
| Q24795672 | The International Sepsis Forum's frontiers in sepsis: High cardiac output should not be maintained in severe sepsis |
| Q52575668 | The Surviving Sepsis Campaign Bundle: 2018 update. |
| Q44320904 | The adrenergic coin: perfusion and metabolism |
| Q36430817 | The choice of catecholamines in septic shock: more and more good arguments to strengthen the known position, but don't lose the faith! |
| Q45265733 | The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock |
| Q42615331 | The lactate:pyruvate ratio following open cardiac surgery in children |
| Q36392628 | The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. |
| Q28068818 | Vasoactive agents for the treatment of sepsis |
| Q52372060 | Vasoplegia treatments: the past, the present, and the future. |
| Q38549220 | Vasopressor and Inotropic Management Of Patients With Septic Shock |
| Q58546619 | Vasopressor use in 41 critically ill cats (2007-2016) |
| Q24186138 | Vasopressors for hypotensive shock |
| Q24234415 | Vasopressors for hypotensive shock |
| Q24246657 | Vasopressors for shock |
| Q26799763 | Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis |
| Q35707635 | Vasopressors in septic shock: a systematic review and network meta-analysis |
| Q80852422 | [Intestinal malperfusion in critical care patients] |
| Q80697200 | [Microcirculation of intensive care patients. From the physiology to the bedside] |
| Q81484333 | [Therapy of organ failure in primary extracardiac diseases] |
Search more.